Last edition
News about Biotechnology
Lupin gets US FDA nod to market generic Kerydin topical solution
Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States Food and Drug Administration (FDA)
Biotechnology | 13/07/2021 | By Darshana | 462
IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry
The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry
Biotechnology | 08/07/2021 | By Darshana | 285
CGT Catapult to expand to Edinburgh BioQuarter to speed up product development
The Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation
Biotechnology | 02/07/2021 | By Darshana | 268
Alembic Pharma receives US FDA approval for generic Macrodantin capsules
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg
Biotechnology | 01/07/2021 | By Darshana | 287
Dr. Reddy's Labs announces commercial launch of 2-DG
Dr Reddy's will supply to major government as well as private hospitals across India. In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India
Biotechnology | 28/06/2021 | By Darshana | 315
Biomerica inks pact with Canadian partner to distribute & market Helicobacter pylori test, hp+detect
Biomerica announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary Helicobacter pylori test, called hp+detect
Biotechnology | 26/06/2021 | By Darshana | 230
Currently, the prevalent approach is to contain the spread of the virus by reducing interpersonal contacts and vaccination. An alternative strategy could involve the understanding of the molecular mechanisms underlying the known risk factors and to correct them, when possible, as a prevention/treatment of the disease
Biotechnology | 24/06/2021 | By Darshana | 420
Can-Fite BioPharma announced the Chinese National Intellectual Property Administration has issued a Notice of Allowance for its patent titled An A3 Adenosine Receptor Ligand for use in Treating Ectopic Fat Accumulation. This patent addresses the use of the A3 Adenosine Receptor (A3AR) ligand, the target receptor for Can-Fite's drug platform technology
Biotechnology | 20/06/2021 | By Darshana | 192
Researchers to have access to Cryo-EM facilities to combat new and emerging diseases
The Department of Science and Technology (DST) has announced that the researchers in the country would soon have access to four Cryogenic-Electron Microscopy (Cryo-EM) facilities paving the way towards establishment of leadership in structural biology, enzymology, and drug discovery to combat new and emerging diseases
Biotechnology | 18/06/2021 | By Darshana | 212
Debiopharm, a Swiss-based global biopharmaceutical company, and Ubix Therapeutics, a South Korea-based biotech company, announced their co-research agreement combining two novel proprietary technologies to specifically target cancer cells
Biotechnology | 17/06/2021 | By Darshana | 459
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy